The link between pregnancy accompanied by Preeclampsia and further Hypertension – a short review of the latest investigations by BIOMEDICA CRO
Women who experience Gestational Hypertension or Preeclampsia have a 2.4-fold increased risk of developing Hypertension 10 years post-pregnancy compared to women who did not experience any Hypertensive Disorders of Pregnancy (HDP), according to the latest study.
Researchers in this study sought to evaluate the prevalence of cardiovascular risk factors and Cardiovascular disease among women with and without a history of HDP 10 years prior.
All women included underwent in-person visits with echocardiography, arterial tonometry, and flow-mediated dilation of the brachial artery. Assessments were completed for 135 patients, of which 84 did have a history of HDP and 51 did not.
Josephine Chou, MD, MS, director of cardio-obstetrics and co-director of maternal cardiology at Yale University School of Medicine, said:
“This study paves the way for future efforts to improve postpartum CV care, enabling us to grasp this opportunity of a lifetime to ultimately reduce maternal and pregnancy-related morbidity and mortality.”
Please find more information on the American College of Cardiology website, article, “Pregnancy-related Hypertension Can Increase Short-term Risk”.
Pregnancy – pregnant donors` biospecimens for research by BIOMEDICA CRO
BIOMEDICA CRO provides both prospective and retrospective collections of the numerous human biospecimen types since 2017.
Basically, we focus on the prospective collections, however, our Biobank cases are also available to order (about 2000 samples, including specimens from pregnant donors).
We routinely collect hundreds of biospecimens from the following groups:
- Diseased patients (wield range of Oncology / Hematology / Cardiology / Dermatology, etc. related indications);
- Healthy donors;
- Pregnant donors (healthy or with specific conditions, such as pregnancy accompanied by Preeclampsia);
- Elderly people, etc.
Today we have 50+ contracted clinical sites in a broad range of disease areas.
Due to our business model and direct way of communication with Primary Investigators you will get the highest quality of human samples and insurance that all project details are followed. Besides biospecimens, you will receive appropriate clinical data, which our physicians can prepare in accordance with your needs.
Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn.
